Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)

OTCMKTS · Delayed Price · Currency is USD

5.20

+2.19 (72.76%)

At close: Nov 7, 2025

73.33% (1Y)

Market Cap	577.82M +73.3%
Revenue (ttm)	1.25M +2,236.3%
Net Income	-154.82K
EPS	-0.00
Shares Out	111.12M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	261
Open	5.20
Previous Close	3.01
Day's Range	4.85 - 5.20
52-Week Range	3.00 - 10.56
Beta	-55.49
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About RAJAF

Cordyceps Sunshine Biotech Holdings Co., Ltd. cultivates and sells Chinese rare medicinal herb, taiwanofungus raw material, and finished products in China. It offers Taiwanofungus Oral pill, a pill form dietary supplement; Taiwanofungus Double A Oral shot; TAIWANOFUNGUS x SALVIA MILTIORRHIZA ORAL Shot; and Collagen Max Drink, a liquid form dietary supplement; and Barbie Coco, a chocolate product. The company also exports its products to Hong Kong and Mainland China. It offers its products through online e-commerce platforms, physical chain stor... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 2020

Employees 16

Stock Exchange OTCMKTS

Ticker Symbol RAJAF

Full Company Profile

Financial Performance

In 2025, RAJAF's revenue was $1.25 million, a decrease of -0.65% compared to the previous year's $1.25 million. Losses were -$154,822, -31.57% less than in 2024.

Financial Statements